EUVIMEDEUVIMED entdecken
Crossref

A Cyclometalated Gold(III) Complex Targets Mitochondrial VDAC1 to Drive Immunometabolic Reprogramming in Cancer

Sean T Gilpatrick, Jong Hyun Kim, Sarayu Bhogoju, Neeraj Kapur, Udara Munugoda, Jovita Daraezinwa, Sean Parkin, Terrence A Barrett, Christine F Brainson iD, Daniel R Plaugher, Samuel G Awuah iD

Journal of the American Chemical Society · 2026

DOI: 10.1021/jacs.6c00003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Sean T Gilpatrick und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Kentucky, Lexington, Kentucky 40506, United States. Hauptthemen laut MEDLINE: Voltage-Dependent Anion Channel 1, Mitochondria, Organogold Compounds, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Voltage-Dependent Anion Channel 1MitochondriaOrganogold CompoundsNeoplasmsAntineoplastic AgentsGoldCoordination ComplexesHumansMetabolic ReprogrammingCell Line, Tumor

Substanzen

Voltage-Dependent Anion Channel 1VDAC1 protein, humanOrganogold CompoundsAntineoplastic AgentsGoldCoordination Complexes

Autor:innen und Institutionen

  • Department of Chemistry, University of Kentucky, Lexington, Kentucky 40506, United States.
  • Department of Medicine, Division of Digestive Diseases and Nutrition, University of Kentucky College of Medicine, Lexington, Kentucky 40506, United States.
  • Lexington Veterans Affairs Medical Center Kentucky, Lexington, Kentucky 40506, United States.
  • Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky 40536, United States.
  • Center for Pharmaceutical Research and Innovation, Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky 40536, United States.
  • Markey NCI Comprehensive Cancer Center, University of Kentucky, Lexington, Kentucky 40536, United States.

ORCID-Profile: Christine F Brainson, Samuel G Awuah

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • CSRD VA
  • NIDDK NIH HHS
  • National Cancer Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • U.S. Department of Veterans Affairs

Zitieren

APA

Gilpatrick, S. T., Kim, J. H., Bhogoju, S., Kapur, N., Munugoda, U., Daraezinwa, J., Parkin, S., Barrett, T. A., Brainson, C. F., Plaugher, D. R., & Awuah, S. G. (2026). A Cyclometalated Gold(III) Complex Targets Mitochondrial VDAC1 to Drive Immunometabolic Reprogramming in Cancer. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c00003

Vancouver

Gilpatrick ST, Kim JH, Bhogoju S, Kapur N, Munugoda U, Daraezinwa J, et al. A Cyclometalated Gold(III) Complex Targets Mitochondrial VDAC1 to Drive Immunometabolic Reprogramming in Cancer. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c00003

BibTeX
@article{Gilpatrick2026,
  author = {Gilpatrick, Sean T and Kim, Jong Hyun and Bhogoju, Sarayu and Kapur, Neeraj and Munugoda, Udara and Daraezinwa, Jovita and Parkin, Sean and Barrett, Terrence A and Brainson, Christine F and Plaugher, Daniel R and Awuah, Samuel G},
  title = {A Cyclometalated Gold(III) Complex Targets Mitochondrial VDAC1 to Drive Immunometabolic Reprogramming in Cancer},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  doi = {10.1021/jacs.6c00003}
}
Kostenlos starten →